Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00489190
Status:
COMPLETED
Last Update Posted:
2009-03-16
First Post:
2007-06-20
Brief Title:
APIDRA Registration Study
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Local Open Non-Randomized Phase IV Clinical Study for the Collection of Data Regarding the Drug Portability Received During the Treatment With Subcutaneous Injection of Apidra Glulisine HMR1964 to Patients With Diabetes Mellitus 1st Type
Status:
COMPLETED
Status Verified Date:
2009-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To collect effectiveness and safety data during the treatment with Apidra glulisine HMR1964 by means of subcutaneous injections to patients with Diabetes Mellitus 1st type during 12 weeks-active phase
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None